KRIT1 ankyrin repeat containing
Última actualización 27 Jun 2022
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
El KRIT1 gene (also known as CCM1) provides instructions for making a protein that strengthens the interactions between cells that form blood vessels and limits leakage from the vessels. The KRIT1 protein interacts with a number of other proteins to form a complex that is found in the junctions that connect neighboring cells. As part of this complex, the KRIT1 protein helps turn off (suppress) a signaling molecule known as RhoA-GTPase. This molecule plays a role in regulating the actin cytoskeleton, which is a network of fibers that makes up the cell's structural framework. When turned on, RhoA-GTPase stimulates the formation of actin fibers, which has been linked to weakened junctions between cells and increased leakage from blood vessels.
Selecciones de videos para GenesBiblioteca de videos
Normal function
El KRIT1 gene (also known as CCM1) provides instructions for making a protein that strengthens the interactions between cells that form blood vessels and limits leakage from the vessels. The KRIT1 protein interacts with a number of other proteins to form a complex that is found in the junctions that connect neighboring cells. As part of this complex, the KRIT1 protein helps turn off (suppress) a signaling molecule known as RhoA-GTPase. This molecule plays a role in regulating the actin cytoskeleton, which is a network of fibers that makes up the cell's structural framework. When turned on, RhoA-GTPase stimulates the formation of actin fibers, which has been linked to weakened junctions between cells and increased leakage from blood vessels.
Conditions referring to this gene or chromosome
Otros nombres
ankyrin repeat-containing protein Krit1
CAM
CCM1
cerebral cavernous malformations 1
krev interaction trapped 1
KRIT1_HUMAN
Related patient information and medicines

Patient information leaflet
Prueba de glucosa en sangre (azúcar en sangre) y HbA1c
...dangerous) Follow Patient: Website: [/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest: [https://uk.pinterest.com/patient/](https://uk.pinterest.com/patient/) Instagram:.

Patient information leaflet
Bursitis olecraniana
Bursitis olecraniana es un condition where there is inflammation and soft swelling at the back of your elbow. The olecranon is the bony tip of your elbow. A bursa is a soft bag of fluid lying over a joint in the body. '-itis' means inflammation. Elbow with olecranon bursitis Olecranon Bursitis Elbow What is olecranon bursitis. Olecranon bursitis,.

Patient information leaflet
Escaneo DMSA
El arrangements, y el way tests are performed, puede vary between diferente hospitals. Always follow the instructions given by your doctor or local hospital. What is a DMSA scan. DMSA stands for dimercaptosuccinic acid. A DMSA scan uses radioactive chemicals to create special pictures of the kidneys. An example of a DMSA scan of the kidneys is.

Patient information leaflet
Tratamiento de la migraña
Prochlorperazine Prochlorperazine comes in a buccal form which dissolves between the gum and cheek. The National Institute for Health and Care Excellence (NICE) has updated its guidance on using metoclopramide or prochlorperazine for people with migraine. They recommend that your doctor discuss the risks and benefits of these medicines with you.

Patient information leaflet
Convulsiones tónico-clónicas
During a generalised tonic clonic seizure, you are unconscious and unaware of what is happ... Duration. This may last from a few seconds to a few minutes. Grand mal seizures Grand mal convulsiones is an older term for generalized tonic-clonic seizures. It has essentially the same meaning, but is no longer used as often by medical professionals. What.

Patient information leaflet
Aerosoles nasales de esteroides
Aerosoles nasales de esteroides son medicamentos that are commonly used to treat clínicos de stuffiness or congestion in the nose. They are used most often for allergies of the nose, such as hay fever. They are also used for other causes of persistent inflammation of the nose ( rhinitis ). Steroid sprays reduce swelling and mucus in the nose, and usually work.
Lecturas adicionales y referencias
- KRIT1 ankyrin repeat containing; MedlinePlus, National Library of Medicine.
- Cave-Riant F, Denier C, Labauge P, Cecillon M, Maciazek J, Joutel A, Laberge-Le Couteulx S, Tournier-Lasserve E. Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations. Eur J Hum Genet. 2002 Nov;10(11):733-40. doi: 10.1038/sj.ejhg.5200870.
- Glading A, Han J, Stockton RA, Ginsberg MH. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol. 2007 Oct 22;179(2):247-54. doi: 10.1083/jcb.200705175.
- Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, Nelson-Williams C, Lifton RP. KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10677-82. doi: 10.1073/pnas.122354499. Epub 2002 Jul 24.
- Guzeloglu-Kayisli O, Kayisli UA, Amankulor NM, Voorhees JR, Gokce O, DiLuna ML, Laurans MS, Luleci G, Gunel M. Krev1 interaction trapped-1/cerebral cavernous malformation-1 protein expression during early angiogenesis. J Neurosurg. 2004 May;100(5 Suppl Pediatrics):481-7. doi: 10.3171/ped.2004.100.5.0481.
- Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet. 1999 Oct;23(2):189-93. doi: 10.1038/13815.
- Plummer NW, Zawistowski JS, Marchuk DA. Genetics of cerebral cavernous malformations. Curr Neurol Neurosci Rep. 2005 Sep;5(5):391-6. doi: 10.1007/s11910-005-0063-7.
- Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010 Apr 12;207(4):881-96. doi: 10.1084/jem.20091258. Epub 2010 Mar 22.
- Verlaan DJ, Davenport WJ, Stefan H, Sure U, Siegel AM, Rouleau GA. Cerebral cavernous malformations: mutations in Krit1. Neurology. 2002 Mar 26;58(6):853-7. doi: 10.1212/wnl.58.6.853.
- Verlaan DJ, Laurent SB, Sure U, Bertalanffy H, Andermann E, Andermann F, Rouleau GA, Siegel AM. CCM1 mutation screen of sporadic cases with cerebral cavernous malformations. Neurology. 2004 Apr 13;62(7):1213-5. doi: 10.1212/01.wnl.0000118299.55857.bb.
- Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development. 2004 Mar;131(6):1437-48. doi: 10.1242/dev.01036.
- Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet. 2005 Sep 1;14(17):2521-31. doi: 10.1093/hmg/ddi256. Epub 2005 Jul 21.
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

